Pharmacy

• Gabapentin Update
• Schedule II Changes Clarification Letter _{(posted 7/08/2024)}
• Standing Order for Naloxone
• Controlled Substances Inventory Log
• Pharmacist in Charge Responsibility Checklist f"] _{(posted 10/01/2023)}
• COVID-Workforce Contingency and Crisis Staffing

Guidance Documents:

• • Utah Guidance for Naloxone _{(posted 9/28/2021)}
  • Utah Guidance for PrEP PEP _{(posted 9/28/2021)}
  • Utah Guidance for Diabetic Therapeutic Equivalents _{(posted 12/14/2023)}
  • Utah Guidance for Tobacco Cessation Products _{(posted 9/28/2021)}
  • Utah Guidance for Epinephrine _{(posted 5/14/2024)}

Vaccine Documents:

• • Vaccine Guidance Document _{(posted 4/10/2024)}
  • Vaccine Protocol _{(posted 9/01/2023)}

Hormonal Contraception:

• • Standing Order for Pharmacist Dispensing of Hormonal Contraception _{(posted 2/06/2024)}
  • Utah Guidance for Administered Hormonal Contraceptives _{(posted 5/14/2024)}

Pharmacy Compounding Task Force:

• • USP <795> FAQs
  • USP <797> FAQs
  • USP <800> FAQs
  • Peer Advisory Committee Application